Holmes Christopher P, Li Xianfeng, Pan Yijun, Xu Caiding, Bhandari Ashok, Moody Claire M, Miguel Joy A, Ferla Steven W, De Francisco M Nuria, Frederick Brian T, Zhou Siqun, Macher Natalie, Jang Larry, Irvine Jennifer D, Grove J Russell
Affymax, Inc., 4001 Miranda Avenue, Palo Alto, CA 94304, USA.
Bioorg Med Chem Lett. 2008 Apr 15;18(8):2719-24. doi: 10.1016/j.bmcl.2008.03.007. Epub 2008 Mar 6.
We have synthesized and evaluated a series of triaryl sulfonamide-based PTP1B inhibitors in which a difluoro-methylenephosphonate group of a potent lead has been replaced by potential bioisosteric replacements. Several mono- or di-charged compounds (8a, 8b, and 15a) were shown exhibit inhibitory activity in the low micromolar range, demonstrating the feasibility of using this approach in identifying non-phosphonate pTyr mimetics in a small molecular scaffold. These results also provide a useful indication of the relative effectiveness of these pTyr mimetics.
我们合成并评估了一系列基于三芳基磺酰胺的蛋白酪氨酸磷酸酶1B(PTP1B)抑制剂,其中一种强效先导化合物的二氟亚甲基膦酸酯基团已被潜在的生物电子等排体取代。几种单电荷或双电荷化合物(8a、8b和15a)在低微摩尔范围内表现出抑制活性,证明了在小分子支架中使用这种方法鉴定非膦酸酯对酪氨酸(pTyr)模拟物的可行性。这些结果也为这些pTyr模拟物的相对有效性提供了有用的指示。